![](https://medcitynews.com/uploads/2021/07/GettyImages-1280895783-150x150.jpg)
![Avatar photo](https://medcitynews.com/uploads/2023/05/Dave-Hanaman-CCO-for-Curavit-Clinical-Research-scaled-96x96.jpg)
![Avatar photo](https://medcitynews.com/uploads/2023/05/Dave-Hanaman-CCO-for-Curavit-Clinical-Research-scaled-150x150.jpg)
Dave Hanaman
Dave Hanaman is co-founder, president, and chief commercial officer of Curavit Clinical Research, a virtual contract research organization (VCRO) that designs and executes decentralized clinical trials and specializing in digital therapeutics. He is a proven entrepreneur, operator, and board director. Founder of C3i, a Business Process Outsourcing (BPO) healthcare provider, Hanaman developed and led its sales, marketing, product development, and alliance strategies. He serves as a board member and advisor to several start-up and growth-stage companies in healthcare and technology. Hanaman graduated from the University of California at Berkeley and served as a deployed U.S. Navy intelligence officer.
-
MedCity Influencers, Health Tech
What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder
By Dave Hanaman
One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested […]
Share/ Jun 12, 2023 at 6:35 PM
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
MedCity >> Inbox
Get the latest industry news first when you subscribe to our newsletter.
We will never sell or share your information without your consent. See our privacy policy.Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.